Simulations Plus, Inc.SLPEarnings & Financial Report
Nasdaq · Information Technology · Services-Computer Integrated Systems Design
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 12.70% | 2.5M | — | 2024-01-23 |
| Conestoga Capital Advisors LLC | 12.10% | 2.4M | — | 2024-01-05 |
| The Vanguard Group | 5.63% | 1.1M | — | 2024-02-13 |
| s/ | 0.00% | 829.2M | ▼ -6.61pp | 2024-08-08 |
Insider Transactions
Net 90d: −$13.4K · buys $0 / sells $13.4KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-15 | DiBella John Anthony II | Chief Revenue Officer | Sell (open market) | 1.0K | $13.37 | $13.4K |
| 2026-02-06 | DiBella John Anthony II | Chief Revenue Officer | Option exercise | 10.3K | $9.71 | $100.0K |
1–2 of 2